Ifosfamide. Metabolic studies, new therapeutic approaches and new analogs

Mini-Reviews in Medicinal Chemistry

Volumn 6, Issue 4, 2006, Pages 395-400

  Misiura, Konrad ^a,b  

^a CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Bromofosfamide; Cyclophosphamide; Ifosfamide; Oxazaphosphorine drugs

Indexed keywords

4 HYDROPEROXYBROMOFOSFAMIDE; 4 HYDROPEROXYIFOSFAMIDE; 4 METHOXYIFOSFAMIDE; ALDOIFOSFAMIDE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BROMOFOSFAMIDE; CAS 3778 73 2; CYCLOPHOSPHAMIDE; CYTOCHROME P450 2B6; CYTOCHROME P450 3A4; GLUFOSFAMIDE; IFOSFAMIDE; IFOSFAMIDE DERIVATIVE; ISOPHOSPHORAMIDE MUSTARD DERIVATIVE; MESNA; N (2 CHLORO 1,1 DIMETHYLETHYL) 3 (2 CHLOROETHYL)TETRAHYDRO 2H 1,3,2 OXAZAPHOSPHORINE 2 AMINE 2 OXIDE; OXAZAPHOSPHORINE DERIVATIVE; SULFONE DERIVATIVE; TROFOSFAMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER DISEASE; CANCER CHEMOTHERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG STRUCTURE; HUMAN; ISOMER; MALIGNANT NEOPLASTIC DISEASE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD; HUMANS; IFOSFAMIDE;

EID: 33646539755     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955706776361385     Document Type: Article

References (71)

1. O'Byrne, K.; Steward, W.P. Oncology, 1999, 56, 13-23.
2. Carli, M.; Passone, E.; Perilongo, G.; Bisogno, G. Oncology, 2003, 65 (Suppl 2), 99-104.
3. Rajski, S.R.; Williams, R.M. Chem. Rev., 1998, 98, 2723-2795.
4. Colvin, E.M.; Sasaki, J.C.; Tran, N.L. Curr. Pharm. Design, 1999, 5, 645-663.
5. Ludeman, S.M. Curr. Pharm. Design, 1999, 5, 627-643.
6. Colvin, O. M. Curr. Pharm. Design, 1999, 5, 555-560.
7. Malet-Martino, M.; Gilard, V.; Martino, R. Curr. Pharm. Design, 1999, 5, 561-586.
8. Gamcsik, M.P.; Dolan, M.E.; Andersson, B.S.; Murray D. Curr. Pharm. Design, 1999, 5, 587-605.
9. Sladek, N.E. Curr. Pharm. Design, 1999, 5, 607-625.
10. Boddy, A.V.; Yule, S.M. Clin. Pharmacokinet., 2000, 38, 291-304.
11. Kerbusch, T.; de Kraker, J.; Keizer, H.J.; van Putten, J.W.; Groen, H.J.; Jansen, R.L.; Schellens, J.H.; Beijnen, J.H. Clin. Pharmacokinet., 2001, 40, 41-62.
12. Baumann, F.; Preiss, R.J. J. Chromatogr. B, 2001, 764, 173-192.
13. Latz, D.; Nassar, N.; Frank, R. Onkologie, 2004, 27, 572-576.
14. Arnold, H.; Bourseaux, F.; Brock, N. Arzneim.-Forsch., 1961, 11, 143-158.
15. Brit. Patent 1 188 159.
16. Pol. Patent 149 593.
17. Pol. Patent 150 330.
18. Pankiewicz, K.; Kinas, R.W.; Stec, W.J.; Foster, A.B.; Jarman, M.; Van Maanen, J.M.S. J. Am. Chem. Soc., 1979, 101, 7712-7718.
19. Williams. M.L.; Wainer, I.W. Curr. Pharm. Design, 1999, 5, 665-672.
20. Furlanut, M.; Franceschi, L. Oncology, 2003, 65 (Suppl 2), 2-6.
21. Nicolao, P.; Giometto, B. Oncology, 2003, 65 (Suppl 2),11-16.
22. Skinner, R. Med. Pediatr. Oncol., 2003, 41, 190-197.
23. Misiura, K.; Okruszek, A.; Pankiewicz, K.; Stec, W.J.; Czownicki, Z.; Utracka, B. J. Med. Chem., 1983, 26, 674-679.
24. Norpoth, K.; Addiks, H.W.; Witting, U.; Muller, G.; Raidt, H. Arzneimforsch., 1975, 25, 1331-1336.
25. Goren, M.P. J. Chromatogr., 1991, 570, 351-359.
26. Wang, J. J.; Chan, K.K. J. Chromatogr. B, Biomed. Appl., 1995, 674, 205-217.
27. Kerbusch, T.; Jeuken, M.J.; Derraz, J.; van Putten, J.W.; Huitema, A.D.; Beijnen, J.H. Ther. Drug Monitor., 2000, 22, 613-620.
28. Gilard, V.; Malet-Martino, M. C.; de Forni, M.; Niemeyer, U.; Ader, J.C.; Martino, R. Cancer Chemother. Pharmacol., 1997, 31, 387-394.
29. Mancini, L.; Payne, G.S.; Dzik-Jurasz, A.S.; Leach, M.O. Magn. Reson. Med., 2003, 50, 249-255.
30. Payne, G.S.; Dzik-Jurasz, A.S.; Mancini L.; Nutley, B.; Raynaud, F.; Leach, M.O. Cancer Chemother. Pharmacol., 2005, 56, 409-414.
31. Misiura, K.; Zielinska, E.; Zubowska, M. Arzneim. Forsch. Drug Res., 2003, 53: 372-377.
32. Schmidt, R.; Baumann, F.; Knupfer, H.; Brauckhoff, M.; Horn, L.C.; Schonfelder, M.; Kohler, U.; Preiss, R. Br. J. Cancer, 2004, 90, 911-916.
33. Aleksa, K.; Matsell, D.; Krausz, K.; Gelboin, H.; Ito, S.; Koren, G. Pediatr. Nephrol., 2005, 20, 872-885.
34. Wainer, I.W.; Durchane, J.; Granvil, C.P.; Trudeau, M.; Leyland-Jones, B. Lancet, 1994, 343, 982-983.
35. Granvil, C.P.; Durchane, J.; Leyland-Jones, B.; Trudeau, M.; Wainer, I.W. Cancer Chemother. Pharmacol., 1996, 37, 451-456.
36. Kusnierczyk, H.; Radzikowski, C.; Paprocka, M.; Budzynski, W.; Rak, J.; Kinas, R.W.; Misiura, K.; Stec, W. J. J. Immunopharmacol., 1986, 8, 455-480.
37. Schmidt, R.; Baumann, F.; Brauckoff, M.; Horn, L.C.; Schonfelder, M.; Kohler, U.; Preiss, R. Br. J. Cancer, 2004, 90, 911-916.
38. Chen, C.S.; Jounaidi, Y.; Waxman, D.J. Drug Metab. Dispos., 2005, 33, 1261-1267.
39. Nicullescu-Duvaz, I.; Spooner, R.; Marais, R.; Springer, C.J. Bioconjugate Chem., 1998, 9, 4-22.
40. Nicullescu-Duvaz, I.; Friedlos, F.; Nicullescu-Duvaz, D.; Davies, L.; Springer, C.J. Anti-Cancer Drug Design, 1999, 14, 517-538.
41. Fillat, C.; Carrio, M.; Cascante, A.; Sangro, B. Curr. Gene Ther., 2003, 3, 13-26.
42. Waxman, D.J.; Chen, L.; Hecht, J.E.D.; Jounaidi, Y. Drug Met. Rev., 1999, 31, 503-522.
43. Chen, L.; Waxman, D.J. Curr. Pharm. Design, 2002, 8, 1405-1416.
44. Kan, O.; Kingsman, S.; Naylor, S. Expert. Opin. Biol. Ther., 2002, 2, 857-868.
45. Patterson, A.V.; Saunders, M.P.; Greco O. Curr. Pharm. Design, 2003, 9, 2131-2154.
46. Misiura, K.; Szymanowicz, D.; Kusnierczyk, H.; Wietrzyk, J.; Opolski, A. Acta Biochim. Pol., 2002, 49, 169-176.
47. Misiura, K.; Szymanowicz, D.; Wietrzyk, J.; Opolski, A. Acta Pol. Pharm. Drug Res., 2003, 60, 109-112.
48. Giaccone, G.; Smit, E.F.; de Jonge, M.; Dansin, E.; Briasoulis, E.; Ardizzoni, A.; Douillard, J.Y.; Spaeth, D.; Lacombe, D.; Baron, B.; Bachmann, P.; Fumoleau, P. Eur. J. Cancer, 2004, 40, 667-672.
49. Aubert, S.D.; Li, Y.; Raushel, F.M. Biochemistry, 2004, 43, 5707-5715.
50. Hernick, M.; Flader, C.; Borch, R.F. J. Med. Chem., 2002, 45, 3540-3548.
51. Niculescu-Duvax, D.; Niculescu-Duvax, I.; Friedlos, F.; Martin, J.; Lehouritis, P.; Marais, R.; Springer, J.C. J. Med. Chem., 2003, 46, 1690-1705.
52. Hu, L.; Yu, C.; Jiang, Y.; Han, J.; Li, Z.; Browne, P.; Race, P.R.; Knox, R.J.; Searle, P.F.; Hyde, E.J. J. Med. Chem., 2003, 46, 4818-4821.
53. Jain, M.; Kwon, C.H. J. Med. Chem., 2003, 46, 5428-5436.
54. Misiura, K.; Kinas, R.W.; Stec, W.J.; Kusnierczyk, H.; Radzikowski, C.; Sonoda, A. J. Med. Chem., 1988, 31, 226-230.
55. Glazman-Kunierczyk, H.; Matuszyk, J.; Radzikowski, C. Immunopharmacol. Immunotoxicol., 1992; 14, 883-911.
56. Sloderbach, A.; Hladon, B.; Sochacki, M.; Kinas, R.W.; Kusnierczyk, H.; Laskowska, H. Pol. J. Pharmacol., 1997; 49, 463-469.
57. Kobylinska, K.; Kobylinska, M.; Sobik, B. Arzneim. Forsch. Drug Res., 2001, 51, 596-599.
58. Juszkiewicz, M.; Kleinrok, Z.; Sawiniec, Z. Arch. Immunol. Ther. Exp., 1994, 42, 405-413.
59. Kusnierczyk, H.; Konarski, L.; Kowalski, P.; Radzikowski, C. Arch. Immunol. Ther. Exp., 1997, 45, 79-85.
60. Kusnierczyk, H.; Pajtasz-Piasecka, E.; Radzikowski, C. Med. Oncol., 1999, 16, 267-278.
61. Misiura, K.; Kinas, R.W.; Kusnierczyk, H.; Radzikowski, C.; Stec, W.J. Anti-Cancer Drugs, 2001, 12, 453-458.
62. Kobylinska, K.; Koralewski, P.; Sobik, B., Gasiorek, M.; Kobylinska, M. Arzneim. Forsch. Drug Res., 2001, 51, 600-603.
63. Misiura, K. Pharmazie, 2004, 59, 668-672.
64. Baraldi, P.G.; Balboni, G.; Romagnoli, R.; Spalluto, G.; Cozzi, P.; Geroni, C.; Mongelli, N.; Rutigliano, C.; Bianchi, N.; Gambari, R. Anticancer Drug Des., 1999, 14, 71-76.
65. Misiura, K.; Kinas, R.W.; Kusnierczyk, H. Bioorg. Med. Chem. Lett., 2002, 12, 156-161.
66. Borner, K.; Kisro, J.; Bruggemann, S.K.; Hagenah, W.; Peters, S.O.; Wagner, T. Drug Metab. Dispos., 2000, 28, 573-576.
67. Misiura, K.; Kardacka, K.; Kusnierczyk H. Arch. Pharm. Pharm. Med. Chem., 2001, 334, 291-294.
68. Paci, A.; Guillaume, D.; Husson, H.P. J. Heterocyclic Chem., 2001, 38, 1131-1134.
69. Misiura, K.; Szymanowicz, D.; Kusnierczyk, H.; Wietrzyk, J.; Opolski, A. Farmaco, 2002, 57, 315-319.
70. Paci, A.; Martens, T.; Royer, J. Bioorg. Med. Chem. Lett., 2001, 11, 1347-1349.
71. Jain, M.; Fan, J.Y.; Baturay, N.Z.; Kwon, C.H. J. Med. Chem., 2004, 47, 3843-3852.